Abstract:Cancer treatment is one of the major public health issues in the world. Tetrandrine (Tet) and fangchinoline (d-Tet) are two bis-benzyl isoquinoline alkaloids extracted from Stephania tetrandra S. Moore, and their antitumor activities have been confirmed. However, the effective dose of Tet and d-Tet were much higher than that of the positive control and failed to meet clinical standards. Therefore, in this study, as a continuation of our previous work to study and develop high-efficiency and low-toxic anti-tumor lead compounds, twenty new Tet and d-Tet derivatives were designed, synthesized and evaluated as antitumor agents against six cancer cell lines (H460, H520, HeLa, HepG-2, MCF-7, SW480 cell lines) and BEAS-2B normal cells by CCK-8 analysis. Ten derivatives showed better cytotoxic effects than the parent fangchinoline, of which 4g showed the strongest cell growth inhibitory activity with an IC50 value of 0.59 μM against A549 cells. Subsequently, the antitumor mechanism of 4g was studied by flow cytometry, Hoechst 33258, JC-1 staining, cell scratch, transwell migration, and Western blotting assays. These results showed that compound 4g could inhibit A549 cell proliferation by arresting the G2/M cell cycle and inhibiting cell migration and invasion by reducing MMP-2 and MMP-9 expression. Meanwhile, 4g could induce apoptosis of A549 cells through the intrinsic pathway regulated by mitochondria. In addition, compound 4g inhibited the phosphorylation of PI3K, Akt and mTOR, suggesting a correlation between blocking the PI3K/Akt/mTOR pathway and the above antitumor activities. These results suggest that compound 4g may be a future drug for the development of new potential drug candidates against lung cancer.

Synthesis and biological evaluation of matrine derivatives containing benzo-α-pyrone structure as potent anti-lung cancer agents

Synthesis and Biological Evaluation of the Matrine Derivatives As a Novel Family of Potential Anticancer Agents

Matrine Induces Caspase-Dependent Apoptosis in Human Osteosarcoma Cells in Vitro and in Vivo Through the Upregulation of Bax and Fas/FasL and Downregulation of Bcl-2

Synthesis, Biological Evaluation and Mechanism Studies of Matrine Derivatives As Anticancer Agents.

Synthesis and Biological Evaluation of Matrine Derivatives As Anti-Hepatocellular Cancer Agents.

Design, Synthesis and Biological Evaluation of Matrine Derivatives As Potential Anticancer Agents.

Synthesis and Anti-cancer Activity of Nitric Oxide Donor-based Matrine Derivatives

Synthesis and Biological Evaluation of Novel Hybrid Matrine Derivatives As Anticancer Agents

Synthesis of Novel Matrine Derivatives Containing Furanone Skeleton and Preliminary Evaluation of Their Anticancer Activity in Vitro

Design, Synthesis, and In vitro Biological Activities of Matrine Skeleton Derivatives as Potential Cancer Inhibitors

Synthesis, characterization and in vitro biological evaluation of two matrine derivatives

Synthesis, Characterization and in Vitro Anti-Tumor Activities of Matrine Derivatives

Matrine Derivative YF-18 Inhibits Lung Cancer Cell Proliferation and Migration Through Down-Regulating Skp2

Matrine Induces the Apoptosis of Lung Cancer Cells Through Downregulation of Inhibitor of Apoptosis Proteins and the Akt Signaling Pathway

Synthesis, Characterization And Activity Evaluation Of Matrinic Acid Derivatives As Potential Antiproliferative Agents

Matrine Reduces Proliferation of Human Lung Cancer Cells by Inducing Apoptosis and Changing Mirna Expression Profiles

Design, Synthesis, and Biological Evaluation of Matrine Derivatives Possessing Piperazine Moiety As Antitumor Agents

Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives

[Advance in Studies on Anti-Tumor Mechanism of Matrine].

Matrine Inhibits the Proliferation and Migration of Lung Cancer Cells Through Regulation of the Protein Kinase B/glycogen Synthase Kinase-3Β Signaling Pathways.

Synthesis and Biological Evaluation of Nitric Oxide-Releasing Matrine Derivatives As Anticancer Agents